Advertisement

Neuroanesthesia and Coexisting Coagulation Problems

  • Massimo LampertiEmail author
  • Andrey Khozhenko
  • Boris Tufegdzic
Chapter

Abstract

Neurosurgical procedures require flawless hemostasis, as even a small bleeding can produce a significant damage, not only impairing a good outcome but causing life-threatening events. Patients requiring general anesthesia for neurosurgical procedures can be affected by inherited or acquired coagulation disorders. While the first are rarer conditions, the latter are becoming more frequent given the increased number of patients receiving anticoagulants and/or antiplatelet medications. Identification of individual patients with preexisting hemostatic defects and an adequate intraoperative monitoring remain crucial to prevent otherwise unexpected bleeding complications, to manage existing bleeding adequately, and to avoid unnecessary patient exposure to blood products.

References

  1. 1.
    Steinberg B, Piccini J. Anticoagulation in atrial fibrillation. Br Med J. 2014;348:g2116.CrossRefGoogle Scholar
  2. 2.
    North American Symptomatic Carotid Endarterectomy Trial Collaborators. Beneficial effect of carotid endarterectomy in symptomatic patients with high-grade carotid stenosis. N Engl J Med. 1991;325:445–53.CrossRefGoogle Scholar
  3. 3.
    Adeeb N, Griessenauer CJ, Foreman PM, et al. Use of platelet function testing before pipeline embolization device placement: a multicenter cohort study. Stroke. 2017;48:1322–30.CrossRefGoogle Scholar
  4. 4.
    Thompson BB, Béjot Y, Caso V, et al. Prior antiplatelet therapy and outcome following intracerebral hemorrhage: a systematic review. Neurology. 2010;75:1333–42.CrossRefGoogle Scholar
  5. 5.
    Pallister CJ, Watson MS. Haematology. Scion Publishing; 2010. p. 334–6.Google Scholar
  6. 6.
    Hoffbrand AV. Essential haematology. Oxford: Blackwell Science; 2002. p. 241–3.Google Scholar
  7. 7.
    Fijnvandraat K, Cnossen MH, Leebeek FWG, et al. Diagnosis and management of haemophilia. Br Med J. 2012;344:e2707.CrossRefGoogle Scholar
  8. 8.
    Khan S, Dickerman JD. Hereditary thrombophilia. Thromb J. 2006;4:15.CrossRefGoogle Scholar
  9. 9.
    Summary of Product Characteristics: Warfarin, Taro Pharmaceuticals UK Ltd, May 2013. www.medicines.org.uk. Accessed 7 Jan 2016.
  10. 10.
    Summary of Product Characteristics: Xarelto, Bayer Plc. 2015. www.medicines.org.uk. Accessed 7 Jan 2016.
  11. 11.
    Connolly SJ, Ezekowitz MD, Yusuf S, et al. Dabigatran versus warfarin in patients with AF. N Engl J Med. 2009;361:1139–51.CrossRefGoogle Scholar
  12. 12.
    Wiviott SD, Braunwald E, McCabe CH, et al. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2010;377:431–41.Google Scholar
  13. 13.
    Wallenten L, Becker RC, Budaj A, et al. Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med. 2009;361:1045–57.CrossRefGoogle Scholar
  14. 14.
    Hegde A, Nair R, Upadhyaya S. Spontaneous intracerebral hemorrhage in hemophiliacs—a treatment dilemma. Int J Surg Case Rep. 2016;29:17–9.CrossRefGoogle Scholar
  15. 15.
    Fawole A, Hamed D, Crowther M. Practical management of bleeding due to the anticoagulants dabigatran, rivaroxaban, and apixaban. Cleve Clin J Med. 2013;80:443–51.CrossRefGoogle Scholar
  16. 16.
    Yu PJ, Cassiere HA, Dellis SL, et al. P2Y12 platelet function assay for assessment of bleeding risk in coronary artery bypass grafting. J Card Surg. 2014;29:312–6.CrossRefGoogle Scholar
  17. 17.
    Nordeen JD, Patel AV, Darracott RM, et al. Clopidogrel resistance by P2Y12 platelet function testing in patients undergoing neuroendovascular procedures. J Vasc Interv Neurol. 2013;6:26–34.PubMedPubMedCentralGoogle Scholar
  18. 18.
    Bolliger D, Seeberger MD, Tanaka KA. Principles and practice of thromboelastography in clinical coagulation management and transfusion practice. Transfus Med Rev. 2012;26:1–13.CrossRefGoogle Scholar
  19. 19.
    Liumbruno GM, Bennardello F, Lattanzio A, et al. Recommendations for the transfusion management of patients in the peri-operative period. I. The pre-operative period. Blood Transfus. 2011;9:19–40.PubMedPubMedCentralGoogle Scholar
  20. 20.
    Stiene-Martin EA, Lotspeich-Steininger CA, Koepke JA. Clinical hematology. Principles, procedures, correlations. 2nd ed. Philadelphia: Lippincott; 1998. p. 599–611.Google Scholar
  21. 21.
    Soghomonyan S, Stoicea N, Sandhu GS. The role of permissive and induced hypotension in current neuroanesthesia practice. Front Surg. 2017;4:1.CrossRefGoogle Scholar
  22. 22.
    Frykholm P, Pikwer A, Hammarskjöld F, et al. Clinical guidelines on central venous catheterization. Acta Anaesthesiol Scand. 2014;58:508–24.CrossRefGoogle Scholar
  23. 23.
    Makris M, Van Veen JJ. Three or four factor prothrombin complex concentrate for emergency anticoagulation reversal? Blood Transfus. 2011;9:117–9.PubMedPubMedCentralGoogle Scholar
  24. 24.
    Baglin TP, Keeling DM, Watson HG. Guidelines on oral anticoagulation (warfarin): third edition—2005 update. Br J Haematol. 2006;132:277–85.CrossRefGoogle Scholar
  25. 25.
    Lin Y, Foltz LM. Proposed guidelines for platelet transfusion. BCMJ. 2005;47(5):245–8.Google Scholar

Copyright information

© Springer Nature Singapore Pte Ltd. 2019

Authors and Affiliations

  • Massimo Lamperti
    • 1
    Email author
  • Andrey Khozhenko
    • 1
  • Boris Tufegdzic
    • 1
  1. 1.Anesthesiology InstituteCleveland Clinic Abu DhabiAbu DhabiUnited Arab Emirates

Personalised recommendations